---
figid: PMC8910500__ijms-23-02410-g001
figtitle: Signal Transduction during Metabolic and Inflammatory Reprogramming in Pulmonary
  Vascular Remodeling
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC8910500
filename: ijms-23-02410-g001.jpg
figlink: /pmc/articles/PMC8910500/figure/ijms-23-02410-f001/
number: F1
caption: Metabolic signaling pathways promoting pulmonary hypertension. During the
  development of pulmonary hypertension, vascular cells release growth factors, which
  activate the hypoxia-inducible factors (HIF). HIF triggers signaling pathways that
  have a direct proliferative effect in both endothelial and smooth muscle cells.
  HIF can also modulate metabolic pathways such as glycolysis, pentose phosphate pathway,
  randle cycle, glutaminolysis and tricarboxylic acid cycle, which activate several
  downstream pathways. (EGFR, epidermal growth factor receptor; FGF2, fibroblast growth
  factor 2; PDGF, platelet-derived growth factor; GLUT, glucose transporter; HIF,
  hypoxia-inducible factors; ROS, reactive oxygen species).
papertitle: Signal Transduction during Metabolic and Inflammatory Reprogramming in
  Pulmonary Vascular Remodeling.
reftext: Marta T. Gomes, et al. Int J Mol Sci. 2022 Mar;23(5):2410.
year: '2022'
doi: 10.3390/ijms23052410
journal_title: International Journal of Molecular Sciences
journal_nlm_ta: Int J Mol Sci
publisher_name: MDPI
keywords: pulmonary arterial hypertension | vascular remodeling | signaling pathways
  | metabolism | inflammation
automl_pathway: 0.8708762
figid_alias: PMC8910500__F1
figtype: Figure
redirect_from: /figures/PMC8910500__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8910500__ijms-23-02410-g001.html
  '@type': Dataset
  description: Metabolic signaling pathways promoting pulmonary hypertension. During
    the development of pulmonary hypertension, vascular cells release growth factors,
    which activate the hypoxia-inducible factors (HIF). HIF triggers signaling pathways
    that have a direct proliferative effect in both endothelial and smooth muscle
    cells. HIF can also modulate metabolic pathways such as glycolysis, pentose phosphate
    pathway, randle cycle, glutaminolysis and tricarboxylic acid cycle, which activate
    several downstream pathways. (EGFR, epidermal growth factor receptor; FGF2, fibroblast
    growth factor 2; PDGF, platelet-derived growth factor; GLUT, glucose transporter;
    HIF, hypoxia-inducible factors; ROS, reactive oxygen species).
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Egfr
  - bnl
  - ras
  - Ras64B
  - Ras85D
  - Raf
  - Dsor1
  - Mtk
  - ap
  - rl
  - ac
  - Pka-C1
  - Pka-R2
  - Pka-C3
  - Pka-R1
  - Pka-C2
  - Pdk1
  - Pdk
  - Coa
  - Akt
  - Pdh
  - Pdha
  - Pdf
  - Pdhb
  - Eaat1
  - Glut1
  - Glut4EF
  - Glut3
  - Hk
  - Zw
  - Ldh
  - Pfk
  - CG15812
  - Pep
  - bgcn
  - Pvr
  - CycE
  - cyc
  - EGFR
  - FGF2
  - FGF13
  - PDGFA
  - PDGFB
  - PDGFC
  - PDGFD
  - KRAS
  - HRAS
  - NRAS
  - RAF1
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - MAPK3
  - MAPK1
  - HIF1A
  - EPAS1
  - HIF3A
  - ARNT
  - ARNT2
  - BMAL1
  - MND1
  - ADCY1
  - ADCY2
  - ADCY3
  - ADCY4
  - ADCY5
  - ADCY6
  - ADCY7
  - ADCY8
  - ADCY9
  - ADCY10
  - PRKAR1A
  - PRKAR1B
  - PRKAR2A
  - PRKAR2B
  - PRKACA
  - PRKACB
  - PRKACG
  - PDK1
  - PDPK1
  - PDK3
  - PDK2
  - PDK4
  - AKT1
  - AKT2
  - AKT3
  - PDP1
  - DLAT
  - DLD
  - PDHA1
  - PDHA2
  - PDHB
  - PDHX
  - SLC2A1
  - G6PD
  - UBL4A
  - LDHA
  - LDHB
  - LDHC
  - PFKL
  - PFKM
  - PFKP
  - PAEP
  - PREP
  - PTPN22
  - KDR
  - FLT1
  - FLT4
---
